Trevi Therapeutics Stock Market Capitalization

TRVI Stock

USD 4.36 0.24 5.83%

Trevi Therapeutics fundamentals help investors to digest information that contributes to Trevi Therapeutics' financial success or failures. It also enables traders to predict the movement of Trevi Stock. The fundamental analysis module provides a way to measure Trevi Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Trevi Therapeutics stock.

		Last Reported	Projected for Next Year
	Market Cap	119.4 M	63.2 M

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Trevi Therapeutics Company Market Capitalization Analysis

Trevi Therapeutics' Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Market Cap

Shares Outstanding

X

Share Price

More About Market Capitalization | All Equity Analysis

Current Trevi Therapeutics Market Capitalization

368.19 M

Most of Trevi Therapeutics' fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Trevi Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Trevi Market Capitalization Driver Correlations

Understanding the fundamental principles of building solid financial models for Trevi Therapeutics is extremely important. It helps to project a fair market value of Trevi Stock properly, considering its historical fundamentals such as Market Capitalization. Since Trevi Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Trevi Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Trevi Therapeutics' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Long Term Debt Total	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Net Debt	Net Invested Capital	Net Working Capital	Capital Stock	Capital Surpluse	Current Deferred Revenue
Total Assets		0.94	0.9	-0.88	0.83	-0.09	0.68	-0.09	-0.6	-0.15	1.0	-0.63	0.66	0.62	-0.3	0.91	0.99	-0.6	0.83	-0.32
Total Stockholder Equity	0.94		0.93	-0.92	0.78	-0.16	0.72	-0.15	-0.72	-0.34	0.94	-0.75	0.69	0.65	-0.42	0.95	0.92	-0.63	0.76	-0.57
Net Tangible Assets	0.9	0.93		-0.92	0.84	0.06	0.72	0.02	-0.5	-0.08	0.9	-0.65	0.5	0.68	-0.52	0.91	0.9	-0.75	0.79	-0.57
Retained Earnings	-0.88	-0.92	-0.92		-0.86	0.14	-0.62	0.24	0.58	0.29	-0.88	0.71	-0.7	-0.59	0.35	-0.93	-0.85	0.66	-0.88	0.54
Accounts Payable	0.83	0.78	0.84	-0.86		0.21	0.71	0.01	-0.39	-0.19	0.83	-0.58	0.5	0.7	-0.29	0.87	0.77	-0.83	0.81	-0.26
Long Term Debt	-0.09	-0.16	0.06	0.14	0.21		0.44	0.91	0.22	0.17	-0.08	-0.1	-0.37	0.56	-0.5	0.04	-0.1	-0.6	-0.24	0.25
Net Receivables	0.68	0.72	0.72	-0.62	0.71	0.44		0.39	-0.7	-0.42	0.68	-0.82	0.48	0.97	-0.78	0.81	0.63	-0.87	0.43	-0.24
Long Term Debt Total	-0.09	-0.15	0.02	0.24	0.01	0.91	0.39		0.16	0.2	-0.09	-0.11	-0.4	0.51	-0.52	-0.03	-0.08	-0.45	-0.42	0.23
Total Liab	-0.6	-0.72	-0.5	0.58	-0.39	0.22	-0.7	0.16		0.72	-0.59	0.88	-0.74	-0.61	0.52	-0.68	-0.54	0.39	-0.39	0.33
Short Long Term Debt	-0.15	-0.34	-0.08	0.29	-0.19	0.17	-0.42	0.2	0.72		-0.15	0.71	-0.68	-0.43	0.22	-0.43	-0.07	0.24	-0.06	0.27
Total Current Assets	1.0	0.94	0.9	-0.88	0.83	-0.08	0.68	-0.09	-0.59	-0.15		-0.62	0.65	0.62	-0.3	0.9	0.99	-0.6	0.83	-0.32
Short Term Debt	-0.63	-0.75	-0.65	0.71	-0.58	-0.1	-0.82	-0.11	0.88	0.71	-0.62		-0.71	-0.83	0.68	-0.81	-0.56	0.69	-0.43	0.42
Common Stock	0.66	0.69	0.5	-0.7	0.5	-0.37	0.48	-0.4	-0.74	-0.68	0.65	-0.71		0.43	-0.15	0.75	0.62	-0.25	0.63	-0.3
Property Plant Equipment	0.62	0.65	0.68	-0.59	0.7	0.56	0.97	0.51	-0.61	-0.43	0.62	-0.83	0.43		-0.76	0.79	0.57	-0.92	0.33	-0.23
Net Debt	-0.3	-0.42	-0.52	0.35	-0.29	-0.5	-0.78	-0.52	0.52	0.22	-0.3	0.68	-0.15	-0.76		-0.47	-0.29	0.68	-0.13	0.4
Net Invested Capital	0.91	0.95	0.91	-0.93	0.87	0.04	0.81	-0.03	-0.68	-0.43	0.9	-0.81	0.75	0.79	-0.47		0.87	-0.76	0.75	-0.48
Net Working Capital	0.99	0.92	0.9	-0.85	0.77	-0.1	0.63	-0.08	-0.54	-0.07	0.99	-0.56	0.62	0.57	-0.29	0.87		-0.54	0.8	-0.34
Capital Stock	-0.6	-0.63	-0.75	0.66	-0.83	-0.6	-0.87	-0.45	0.39	0.24	-0.6	0.69	-0.25	-0.92	0.68	-0.76	-0.54		-0.45	0.32
Capital Surpluse	0.83	0.76	0.79	-0.88	0.81	-0.24	0.43	-0.42	-0.39	-0.06	0.83	-0.43	0.63	0.33	-0.13	0.75	0.8	-0.45		-0.35
Current Deferred Revenue	-0.32	-0.57	-0.57	0.54	-0.26	0.25	-0.24	0.23	0.33	0.27	-0.32	0.42	-0.3	-0.23	0.4	-0.48	-0.34	0.32	-0.35

Click cells to compare fundamentals

Trevi Market Capitalization Historical Pattern

Today, most investors in Trevi Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Trevi Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's market capitalization growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Trevi Therapeutics market capitalization as a starting point in their analysis.

Trevi Therapeutics Market Capitalization

Timeline

In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

Competition

Predict Trevi Therapeutics

Market Cap Over Time

Trevi Long Term Debt To Capitalization

Long Term Debt To Capitalization

0.0168

As of now, Trevi Therapeutics' Long Term Debt To Capitalization is increasing as compared to previous years.

Based on the recorded statements, the market capitalization of Trevi Therapeutics is about 368.19 M. This is 97.15% lower than that of the Pharmaceuticals sector and 92.23% lower than that of the Health Care industry. The market capitalization for all United States stocks is 98.07% higher than that of the company.

Trevi Market Capitalization Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Trevi Therapeutics' direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Trevi Therapeutics could also be used in its relative valuation, which is a method of valuing Trevi Therapeutics by comparing valuation metrics of similar companies.

Trevi Therapeutics is currently under evaluation in market capitalization category among its peers.

Trevi Therapeutics Current Valuation Drivers

We derive many important indicators used in calculating different scores of Trevi Therapeutics from analyzing Trevi Therapeutics' financial statements. These drivers represent accounts that assess Trevi Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Trevi Therapeutics' important valuation drivers and their relationship over time.

	2020	2021	2022	2023	2024	2025 (projected)
Market Cap	43.7M	17.9M	124.6M	132.7M	119.4M	63.2M
Enterprise Value	12.9M	(4.3M)	121.2M	101.6M	116.9M	64.4M

Trevi Therapeutics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Trevi Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Trevi Therapeutics' managers, analysts, and investors.

Environmental

Governance

Social

Trevi Fundamentals

	Return On Equity	-0.6
	Return On Asset	-0.37
	Current Valuation	303.81 M
	Shares Outstanding	89.37 M
	Shares Owned By Insiders	1.00 %
	Shares Owned By Institutions	70.42 %
	Number Of Shares Shorted	4.66 M
	Price To Book	6.24 X
	EBITDA	(33.8 M)
	Net Income	(29.07 M)
	Cash And Equivalents	77.86 M
	Cash Per Share	1.82 X
	Total Debt	1.34 M
	Debt To Equity	0.21 %
	Current Ratio	5.18 X
	Book Value Per Share	0.78 X
	Cash Flow From Operations	(31.71 M)
	Short Ratio	1.30 X
	Earnings Per Share	(0.44) X
	Target Price	9.81
	Number Of Employees	27
	Beta	1.01
	Market Capitalization	368.19 M
	Total Asset	89.4 M
	Retained Earnings	(239.13 M)
	Working Capital	81.72 M
	Net Asset	89.4 M

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC